EU poised to secure 1.8bn 2nd-generation vaccine doses

BRUSSELS: The EU is about to start negotiations with a single pharmaceutical company to secure up to 1.8 billion doses of a “second generation” mRNA vaccine to combat future variants, a European Commission source said.

The upcoming deal aims to have deliveries made on a monthly schedule starting late this year and going into 2023, the source told AFP.